Physician profile
Rahul Sood
NPI 1861625279
$3,759.78
in general payments reported to CMS, 2019-2025
38 companies · $512 in 2025
The $512 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $576 · 2020: $308 · 2021: $514 · 2022: $454 · 2023: $706 · 2024: $690 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,717 · Travel and Lodging: $159 · Education: $31.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,716.54 |
| Travel and Lodging | $159.33 |
| Education | $31.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $733.24 | 2023-2025 | Prospera, Biotronik |
| Boston Scientific Corporation | $712.58 | 2019-2023 | |
| Nevro Corp. | $294.21 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $240.27 | 2023-2025 | Relistor |
| Bard Peripheral Vascular, INC. | $205.53 | 2023 | Venclose Maven Catheter |
| Collegium Pharmaceutical, INC. | $203.04 | 2019-2025 | Xtampza, Belbuca |
| Medtronic USA, INC. | $157.37 | 2019-2020 | |
| Curonix LLC | $130.47 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $125.60 | 2021-2023 | Closurefast, Intellis Adaptivestim |
| Vertiflex, INC. | $118.33 | 2019 | |
| Protega Pharmaceutials INC | $82.08 | 2023-2025 | Roxybond |
| Nuvasive, INC. | $78.41 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $72.01 | 2022-2023 | Seglentis |
| Biodelivery Sciences International, INC. | $70.09 | 2020-2021 | |
| Si-Bone, INC. | $53.39 | 2022-2023 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $39.22 | 2019 | |
| Avanos Medical | $38.67 | 2022-2023 | Trivisc Sodium Hyaluronate |
| Stimwave Technologies Incorporated | $36.17 | 2019 | |
| Seapearl East, INC | $33.63 | 2021 | |
| Grt US Holding, INC. | $28.44 | 2021-2022 | |
| Tactile Systems Technology INC | $24.86 | 2025 | Nimbl, Flexitouch Plus |
| Depuy Synthes Sales INC. | $23.49 | 2024 | Monovisc |
| Pacira Pharmaceuticals Incorporated | $21.77 | 2022 | |
| Ossur Americas, INC. | $20.10 | 2025 | Unloader One X |
| Valinor Pharma, LLC | $19.80 | 2025 | Movantik |
| Merck Sharp & Dohme LLC | $17.38 | 2022 | |
| Nalu Medical, INC. | $16.60 | 2023 | Nalu Neurostimulation System |
| Janssen Biotech, INC. | $16.44 | 2023 | Stelara |
| Forte Bio-Pharma LLC | $16.39 | 2025 | Prolate, Nalocet, Tanlor |
| Virtus Pharmaceuticals LLC | $15.95 | 2025 | Levorphanol Tartrate |
| Almatica Pharma LLC | $15.77 | 2023 | Gralise |
| Baudax Bio INC. | $15.00 | 2020 | |
| Azurity Pharmaceuticals, INC. | $14.69 | 2025 | Horizant |
| Teva Pharmaceuticals USA, INC. | $14.54 | 2019 | |
| Eagle Pharmaceuticals, INC. | $14.38 | 2023 | |
| Scilex Pharmaceuticals INC. | $14.06 | 2022 | |
| Allergan, INC. | $13.33 | 2021 | |
| Redhill Biopharma INC. | $12.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Sood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.